EUnetHTA Conference: HTA's Future in Europe

November 20, 2008
Pasteur Institute, Paris, France
Health technology is the application of scientific knowledge in health care and prevention. Health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value.

Detailed programme will be available at a later date. To receive updated information regarding the conference, please subscribe to the update service at http://www.eunethta.net/Home/
EUnetHTA_Conference_2008_in__Paris/

The plenary will include presentations on the results from the EUnetHTA project:

  • Core HTA Model
  • HTA Adaptation toolkit
  • New technologies monitoring system
  • Emerging technologies information system
  • HTA and health policy
  • HTA capacity building
  • EUnetHTA HTA information system

The Conference will be held at the Scientific International Center of the Pasteur Institute.
These facilities are conveniently located downtown Paris (Metro Pasteur; Gare Montparnasse)
The official language of the conference is English. Simultaneous interpretation will be available in French and Spanish.

For further information, please visit:
http://www.eunethta.net/Home/
EUnetHTA_Conference_HTAs_Future_in_Europe/

About European network for Health Technology Assessment (EUnetHTA)
In 2004 the European Commission and Council of Ministers targeted Health Technology Assessment (HTA) as "a political priority", recognising "...an urgent need for establishing a sustainable European network on HTA". A Commission call was answered in 2005 by a group of 35 organisations throughout Europe, led by the Danish Centre for Evaluation and HTA (DACEHTA) in Copenhagen.

European network for Health Technology Assessment, EUnetHTA, coordinates the efforts of 27 European countries including 25 Member States of the European Union in evaluating health technology in Europe.

The general strategic objective of the Network:
to connect public national/regional HTA agencies, research institutions and health ministries, enabling an effective exchange of information and support to policy decisions by the Member States. Specific Objectives...

During the first 3 years of existence (2006-2008) EUnetHTA aims at developing an organisational framework for a sustainable European network for HTA along with practical tools to fill into this framework to ensure timely and effective production, dissemination and transfer of HTA results into useful policy advice to the Member States and EU.

Initially, the EUnetHTA project is being co-financed by the European Commission (DG Sanco) and contributions from network members.

Progress reports and information on EUnetHTA activities involving a wider stakeholder group will be continuously available on the Eunethta website, http://www.eunethta.net.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...